merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 annual cap on patient costs for drugs taken at home will go into effect next year, which is before the new negotiated prices take effect in 2026.</answer>
<question_number>2</question_number>
<answer>The number of drugs negotiated by the federal government is set to increase in the coming years, and the Project 2025 playbook suggests that the drug price negotiation program should be repealed if former President Donald J. Trump wins the White House in November, particularly with full Republican control of Congress.</answer>
<question_number>3</question_number>
<answer>Ms. Harris has focused some of her early presidential campaign on the Biden administration's drug pricing reforms, including the cap on monthly insulin costs for Medicare recipients.</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>$1,320</answer>
<question_number>6</question_number>
<answer>Johnson & Johnson</answer>
<question_number>7</question_number>
<answer>Imbruvica</answer>
<question_number>8</question_number>
<answer>63.5%</answer>
<question_number>9</question_number>
<answer>$197</answer>
<question_number>10</question_number>
<answer>$11,969</answer>